EYPT · EyePoint Inc
United States · RS rating 3 · As of 2026-10-14
| Price | 3.01 USD |
|---|---|
| 1-day change | -1.9% |
| RS rating (overall / 1M / 3M / 12M) | 3 / 13 / 2 / 7 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 20 / 18 / 4 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | +4.7% |
| Sales growth Q/Q | -35.8% |
| Distance from 52-week high | +84.0% |
| Market cap (USD) | $1.2B |